<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Review of the policy on Foreign Direct Investment in pharmaceuticals sectorinsertion of a new paragraph 6.2.25 to &#039;Circular 2 of 2011-Consolidated FDI Policy&#039; .</title>
    <link>https://www.taxtmi.com/circulars?id=11370</link>
    <description>Amendment to the consolidated FDI policy inserts paragraph 6.2.25: greenfield pharmaceutical projects are permitted FDI under the automatic route, while existing (brownfield) pharmaceutical companies are permitted FDI only under the government approval route; the change takes immediate effect and will be reviewed after six months.</description>
    <language>en-us</language>
    <pubDate>Tue, 08 Nov 2011 00:00:00 +0530</pubDate>
    <lastBuildDate>Tue, 08 Nov 2011 17:21:00 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=265607" rel="self" type="application/rss+xml"/>
    <item>
      <title>Review of the policy on Foreign Direct Investment in pharmaceuticals sectorinsertion of a new paragraph 6.2.25 to &#039;Circular 2 of 2011-Consolidated FDI Policy&#039; .</title>
      <link>https://www.taxtmi.com/circulars?id=11370</link>
      <description>Amendment to the consolidated FDI policy inserts paragraph 6.2.25: greenfield pharmaceutical projects are permitted FDI under the automatic route, while existing (brownfield) pharmaceutical companies are permitted FDI only under the government approval route; the change takes immediate effect and will be reviewed after six months.</description>
      <category>Circulars</category>
      <law>FEMA</law>
      <pubDate>Tue, 08 Nov 2011 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/circulars?id=11370</guid>
    </item>
  </channel>
</rss>